Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs
Bullboard Posts
User Avatar Image
(21)
•••
Comment by Sinbobon Feb 10, 2013 2:46pm
189 Views
Post# 20965357

RE: RE: It's a 'western' thing...

RE: RE: It's a 'western' thing...

Well you know JD, I thought the NR this week, all the NR's to date, all of pmrider's posts to date ( he is the best ) and all the great info on the BTI website, plus a few phone calls here and there ... and some excellent posts here by several astute investors... has it pretty well covered... and it has all been pretty well discussed.  I'm desperately trying to grasp the significance of it all of course. The rest is personal opinions, interpretations, predictions, interesting discussions and hints from some that they have special knowledge that others either are simply not intelligent enough to understand, or are simply not privy to. How could I possibly add to all that? Thanks for the vote of confidence though. Anything I might add has already been discussed, so why bother? I'm sure you have that all covered and if it occurs to you, I'm sure you will post it here or on your blog.

 

I think there are others here vying for your attention ... and on your blog... and I' not being snarky like some of them, so don't take that the wrong way. No doubt there are a lot of interested folks that you can enlighten.

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities